Company news: HGS, biotechs' regulatory distress and oncologists for more details
Human Genome Sciences is eliminating 150 positions in manufacturing, R&D and administration due to slow sales of its drug Benlysta.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.